Problem statement: Answer the MCQ question.
Query: Which drug exhibits a -15.837% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CC(=O)c1cccc(NC(=O)C2C3C=CC(C3=C(c3ccccc3)c3ccccc3)C2C(=O)O)c1
(b) COCCN1C(=S)N[C@@H](c2cccc(F)c2)C(C(=O)OC)=C1C
Answer: b. COCCN1C(=S)N[C@@H](c2cccc(F)c2)C(C(=O)OC)=C1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCN1C(=S)N[C@@H](c2cccc(F)c2)C(C(=O)OC)=C1C
COCCN1C(=S)N[C@@H](c2cccc(F)c2)C(C(=O)OC)=C1C
methyl (6S)-6-(3-fluorophenyl)-3-(2-methoxyethyl)-4-methyl-2-sulfanylidene-1,6-dihydropyrimidine-5-carboxylate